Telormedix SA
6Patents
6Active
6Granted
44Portfolio score
Filing activity: Feb 5, 2010 → Feb 25, 2013 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9173935B2 | Phospholipid drug analogs | Emerging Cross-Sectional Technologies | 20 | Active |
| US9050319B2 | Phospholipid drug analogs | Human Necessities | 2 | Active |
| US9173936B2 | Phospholipid drug analogs | Emerging Cross-Sectional Technologies | 2 | Active |
| US9180183B2 | Phospholipid drug analogs | Emerging Cross-Sectional Technologies | 2 | Active |
| US9107919B2 | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration | Emerging Cross-Sectional Technologies | 0 | Active |
| US9066940B2 | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.